Literature DB >> 19338473

Establishment of drug-resistant HIV-1 in latent reservoirs.

Viktor Dahl1, Sarah Palmer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19338473     DOI: 10.1086/597760

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  9 in total

1.  Galectin-1-specific inhibitors as a new class of compounds to treat HIV-1 infection.

Authors:  Christian St-Pierre; Michel Ouellet; Denis Giguère; Reiko Ohtake; René Roy; Sachiko Sato; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2011-11-07       Impact factor: 5.191

Review 2.  HIV reservoirs and latency models.

Authors:  Matthew J Pace; Luis Agosto; Erin H Graf; Una O'Doherty
Journal:  Virology       Date:  2011-02-01       Impact factor: 3.616

3.  Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs.

Authors:  Luis M Agosto; Megan K Liszewski; Angela Mexas; Erin Graf; Matthew Pace; Jianqing J Yu; Avinash Bhandoola; Una O'Doherty
Journal:  Virology       Date:  2011-01-05       Impact factor: 3.616

4.  Provirus activation plus CD59 blockage triggers antibody-dependent complement-mediated lysis of latently HIV-1-infected cells.

Authors:  Jie Lan; Kai Yang; Daniel Byrd; Ningjie Hu; Tohti Amet; Nicole Shepherd; Mona Desai; Jimin Gao; Samir Gupta; Yongtao Sun; Qigui Yu
Journal:  J Immunol       Date:  2014-08-22       Impact factor: 5.422

Review 5.  Facts and fiction: cellular models for high throughput screening for HIV-1 reactivating drugs.

Authors:  Vicente Planelles; Frank Wolschendorf; Olaf Kutsch
Journal:  Curr HIV Res       Date:  2011-12-01       Impact factor: 1.581

6.  Blockage of CD59 Function Restores Activities of Neutralizing and Nonneutralizing Antibodies in Triggering Antibody-Dependent Complement-Mediated Lysis of HIV-1 Virions and Provirus-Activated Latently Infected Cells.

Authors:  Kai Yang; Jie Lan; Nicole Shepherd; Ningjie Hu; Yanyan Xing; Daniel Byrd; Tohti Amet; Corlin Jewell; Samir Gupta; Carole Kounga; Jimin Gao; Qigui Yu
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

7.  Reactivation of latent HIV-1 by inhibition of BRD4.

Authors:  Jian Zhu; Gaurav D Gaiha; Sinu P John; Thomas Pertel; Christopher R Chin; Geng Gao; Hongjing Qu; Bruce D Walker; Stephen J Elledge; Abraham L Brass
Journal:  Cell Rep       Date:  2012-10-04       Impact factor: 9.423

8.  Dual-acting stapled peptides target both HIV-1 entry and assembly.

Authors:  Hongtao Zhang; Francesca Curreli; Abdul A Waheed; Peter Y Mercredi; Mansi Mehta; Pallavi Bhargava; Daniel Scacalossi; Xiaohe Tong; Shawn Lee; Alan Cooper; Michael F Summers; Eric O Freed; Asim K Debnath
Journal:  Retrovirology       Date:  2013-11-15       Impact factor: 4.602

9.  R88-APOBEC3Gm Inhibits the Replication of Both Drug-resistant Strains of HIV-1 and Viruses Produced From Latently Infected Cells.

Authors:  Xiaoxia Wang; Zhujun Ao; Kallesh Danappa Jayappa; Bei Shi; Gary Kobinger; Xiaojian Yao
Journal:  Mol Ther Nucleic Acids       Date:  2014-03-04       Impact factor: 10.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.